For: | Mondal S, Pramanik S, Khare VR, Fernandez CJ, Pappachan JM. Sodium glucose cotransporter-2 inhibitors and heart disease: Current perspectives. World J Cardiol 2024; 16(5): 240-259 [PMID: 38817648 DOI: 10.4330/wjc.v16.i5.240] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v16/i5/240.htm |
Number | Citing Articles |
1 |
Xinyue Zhang, Yanxia Zhang, Jiayu Wang, Zhijia Tang. Sodium-glucose cotransporter 2 inhibitors in the treatment of heart failure patients: A systematic review and meta-analysis of cost-utility studies. Archives of Gerontology and Geriatrics 2025; 133: 105809 doi: 10.1016/j.archger.2025.105809
|
2 |
Elena Y. Rykova, Vadim V. Klimontov, Elena Shmakova, Anton I. Korbut, Tatyana I. Merkulova, Julia Kzhyshkowska. Anti-Inflammatory Effects of SGLT2 Inhibitors: Focus on Macrophages. International Journal of Molecular Sciences 2025; 26(4): 1670 doi: 10.3390/ijms26041670
|
3 |
Murali Krishna Moka, Melvin George, Deepalaxmi Rathakrishnan, V Jagadeeshwaran, Sriram D K. Trends in drug repurposing: Advancing cardiovascular disease management in geriatric populations. Current Research in Translational Medicine 2025; 73(2): 103496 doi: 10.1016/j.retram.2025.103496
|
4 |
Samar Abed Alharbi, Amal Ahmad Alsubaiei, Ali Hussain Alkhalifah, Abdulrahman Abdulaziz Alshehri, Shoog Soliman Alhaggas, Shahad Marwan Alhuthli, Yousef Hassan Alfaqih, Wed Ziyad Alnajjar, Ghaida Abdulla Alshaban, Mahmood Sameer Ahmed, Abdulkarem Sarhan Alqarni. The role of SGLT2 inhibitors in protecting cardiovascular health: beyond glycaemic control. International Journal Of Community Medicine And Public Health 2025; doi: 10.18203/2394-6040.ijcmph20250050
|
5 |
Rebecca Ayoti, Zahid Khan, Gideon Mlawa, Animesh Gupta. Assessing the Effectiveness and Safety of Combination Diuretic Therapy in Heart Failure: A Systematic Review and Meta-Analysis. Cureus 2024; doi: 10.7759/cureus.72118
|